| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.009 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |